Advertisement

Topics

Investigational Alzheimer's Drug Shows Early Promise

16:36 EDT 26 Jul 2018 | NEJM

An unapproved drug shows promise in terms of slowing cognitive decline in patients with early Alzheimer disease, according to results of a phase II trial...

Original Article: Investigational Alzheimer's Drug Shows Early Promise

NEXT ARTICLE

More From BioPortfolio on "Investigational Alzheimer's Drug Shows Early Promise"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...